The relationship between the level of albuminuria and severity of impairment in pulmonary function in type II diabetic patients

  • Zahraa A. Al-Mudhafer Department of Physiology/College of Medicine –University of Kufa/ Iraq
  • Nibras H. Abdulsada Al-Ghuraibawi 2Department of Pharmacology/College of pharmacy –University of Kufa/ Iraq
  • Salam J. Mohammed 3Department head of Community medicine/College of Medicine –University of Kufa/ Iraq

Abstract

Diabetes mellitus type II can lead to acute and chronic complications. The progression of many complications might be explained via modification of connective tissue and microangiopathy. The major microvascular structure in the body is the pulmonary alveolar- capillary network, which might be influenced by diabetic microangiopathy. Diabetic nephropathy (DN) remains a major end-organ complication in diabetes. Complications of diabetes including pulmonary dysfunction and diabetic nephropathy have an analogous microangiopathic origin. There are numerous studies cover the relationship between albuminuria and lung impairment in type I diabetic patients, but few studies about this relationship in type II diabetic patients, so current study aimed To assess the relationship between the levels of albuminuria and pulmonary function in diabetic patients type II. The design of the study is a cross-sectional study included 245 types II diabetic patients (119 male and 126 female), aged 41-80 years with mean ± SEM (57.43±0.54 years). Spirometry was done for all patients. Albumin/creatinine ratio and HbA1c were measured. There was a significant statistical negative relationship between ACR with FEV1 (% predicted) and FVC (% predicted). The progression of diabetic nephropathy to further advanced stages is associated with further changes in pulmonary function.

Article Level Metrics

Download data is not yet available.
Published
2019-02-02
How to Cite
AL-MUDHAFER, Zahraa A.; AL-GHURAIBAWI, Nibras H. Abdulsada; MOHAMMED, Salam J.. The relationship between the level of albuminuria and severity of impairment in pulmonary function in type II diabetic patients. International Journal of Research in Pharmaceutical Sciences, [S.l.], v. 10, n. 1, p. 174-178, feb. 2019. ISSN 0975-7538. Available at: <https://pharmascope.org/index.php/ijrps/article/view/1797>. Date accessed: 20 feb. 2019. doi: https://doi.org/10.26452/ijrps.v10i1.1797.
Section
Original Articles
Bookmark and Share